Direkt zum Inhalt
Merck
Alle Fotos(2)

Wichtige Dokumente

Gesamtdokumentation anzeigen

D9035

Sigma-Aldrich

Diazoxid

≥98% (TLC), powder, ATP-sensitive K⁺ channel activator

Synonym(e):

7-Chlor-3-methyl-2H-1,2,4-benzothiadiazin-1,1-dioxid

Anmeldenzur Ansicht organisationsspezifischer und vertraglich vereinbarter Preise

Größe auswählen

250 MG
€ 101,00
1 G
€ 307,00
5 G
€ 1.220,00

€ 101,00

Check Cart for Availability
Bulk-Bestellung anfordern
Alle Fotos(2)

Größe auswählen

Ansicht ändern
250 MG
€ 101,00
1 G
€ 307,00
5 G
€ 1.220,00

About This Item

Empirische Formel (Hill-System):
C8H7ClN2O2S
CAS-Nummer:
364-98-7
Molekulargewicht:
230.67
EG-Nummer:
206-668-1
MDL-Nummer:
MFCD00078578
UNSPSC-Code:
12352119
PubChem Substanz-ID:
24277831
NACRES:
NA.77

€ 101,00

Check Cart for Availability
Bulk-Bestellung anfordern

Produktbezeichnung

Diazoxid,

Form

powder

Löslichkeit

0.1 M NaOH: soluble
H2O: insoluble
methanol: soluble

Ersteller

Schering Plough

SMILES String

CC1=Nc2ccc(Cl)cc2S(=O)(=O)N1

InChI

1S/C8H7ClN2O2S/c1-5-10-7-3-2-6(9)4-8(7)14(12,13)11-5/h2-4H,1H3,(H,10,11)

InChIKey

GDLBFKVLRPITMI-UHFFFAOYSA-N

Angaben zum Gen

human ... KCNA1(3736) , KCNJ11(3767) , KCNJ8(3764) , KCNMA1(3778)
mouse ... Kcnj1(56379) , Kcnj11(16514)
rat ... Gria1(50592) , Kcna1(24520) , Kcnj1(24521) , Kcnj11(83535) , Kcnj8(25472)

Suchen Sie nach ähnlichen Produkten? Aufrufen Leitfaden zum Produktvergleich

Allgemeine Beschreibung

Diazoxide is a nondiuretic benzothiadiazine,[1] which is used for the treatment of hypoglycemia, von Gierke′s disease, acute and malignant hypertension. It acts as a beta cell KATP channel opener. Diazoxide prevents the secretion of insulin.[2]

Anwendung

Diazoxide has been used for diazoxide infusion.[3][4] It has also been used to prevent depolarization for K+-induced exocytosis.[5]

Biochem./physiol. Wirkung

Selective ATP-sensitive K+ channel activator in both vascular smooth muscle and pancreatic β-cells; antihypertensive.

Leistungsmerkmale und Vorteile

This compound is featured on the Potassium Channels page of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here.
This compound was developed by Schering Plough. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.

Piktogramme

Exclamation mark
GHS07

Signalwort

Warning

Gefahreneinstufungen

Acute Tox. 4 Oral - Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3

Zielorgane

Respiratory system

Lagerklassenschlüssel

11 - Combustible Solids

WGK

WGK 3

Flammpunkt (°F)

Not applicable

Flammpunkt (°C)

Not applicable

Persönliche Schutzausrüstung

dust mask type N95 (US), Eyeshields, Gloves

Hier finden Sie alle aktuellen Versionen:

Analysenzertifikate (COA)

Lot/Batch Number
BCCL3550
WXBF2299V
BCCF3412
BCCB0466
BCBX4929

Die passende Version wird nicht angezeigt?

Wenn Sie eine bestimmte Version benötigen, können Sie anhand der Lot- oder Chargennummer nach einem spezifischen Zertifikat suchen.

Suche nach COA

Besitzen Sie dieses Produkt bereits?

In der Dokumentenbibliothek finden Sie die Dokumentation zu den Produkten, die Sie kürzlich erworben haben.

Die Dokumentenbibliothek aufrufen

N D'hahan et al.
Proceedings of the National Academy of Sciences of the United States of America, 96(21), 12162-12167 (1999-10-16)
The pharmacological phenotype of ATP-sensitive potassium (K(ATP)) channels is defined by their tissue-specific regulatory subunit, the sulfonylurea receptor (SUR), which associates with the pore-forming channel core, Kir6.2. The potassium channel opener diazoxide has hyperglycemic and hypotensive properties that stem from
T Grimmsmann et al.
British journal of pharmacology, 123(5), 781-788 (1998-04-16)
1. The direct effects of diazoxide on mitochondrial membrane potential, Ca2+ transport, oxygen consumption and ATP generation were investigated in mouse pancreatic B-cells and rat liver mitochondria. 2. Diazoxide, at concentrations commonly used to open adenosine 5'-triphosphate (ATP)-dependent K+-channels (K(ATP)
Glucose-dependent granule docking limits insulin secretion and Is decreased in human type 2 diabetes
Gandasi NR, et al.
Cell Metabolism, 27(2), 470-478 (2018)
Aharon Helman et al.
Cell metabolism, 31(5), 1004-1016 (2020-05-07)
A drastic transition at birth, from constant maternal nutrient supply in utero to intermittent postnatal feeding, requires changes in the metabolic system of the neonate. Despite their central role in metabolic homeostasis, little is known about how pancreatic β cells
Hiromi Nakai-Shimoda et al.
iScience, 25(1), 103609-103609 (2022-01-11)
Glucose-responsive ATP-sensitive potassium channels (KATP) are expressed in a variety of tissues including nervous systems. The depolarization of the membrane potential induced by glucose may lead to hyperexcitability of neurons and induce excitotoxicity. However, the roles of KATP in the
Alle zugehörigen Dokumente anzeigen

Questions

Reviews

No rating value

Active Filters

Unser Team von Wissenschaftlern verfügt über Erfahrung in allen Forschungsbereichen einschließlich Life Science, Materialwissenschaften, chemischer Synthese, Chromatographie, Analytik und vielen mehr..

Setzen Sie sich mit dem technischen Dienst in Verbindung.